Literature DB >> 16636101

Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons.

Aiqun Li1, Hong Guo, Xiaoying Luo, Jiansong Sheng, Shuo Yang, Yanqing Yin, Jianwei Zhou, Jiawei Zhou.   

Abstract

Apomorphine (APO), a potent D1/D2 dopamine receptor agonist, is currently used as an antiparkinsonian drug. We have shown previously that APO stimulates synthesis and release of multiple trophic factors, such as brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF), in both mesencephalic and striatal neurons, thereby effectively preventing dopaminergic neuron loss in vitro. The present study was designed to investigate the effects of APO on fibroblast growth factor-2 (FGF-2) expression and regulation in astrocytes, and furthermore, to identify signaling mechanisms underlying these effects. Here, we show that FGF-2 expression is robustly induced in cultured astrocytes in response to APO. FGF-2 expression was proportional to APO concentration and time-dependent. Conversely, treatment with S-APO, a derivative of R-APO lacking DA receptor agonist activity, did not alter FGF-2 levels. APO treatment resulted in enhanced cytosol FGF-2 immunoreactivity, export of high MW forms of FGF-2 to the cytoplasm from the nucleus and increased extracellular release of FGF-2. Interestingly, both high and low MW forms of FGF-2 were detectable in conditioned medium of APO-treated cultures. This APO-induced effect was correlated with activation of D1 and D2 receptors, as it could be either mimicked by dopamine receptor agonists (SKF38393, quinpirole) or partially blocked by antagonists (SCH23390, SKF83566, haloperidol). Activation of the D1 receptor preferentially increased PKA activity, whereas activation of the D2 receptor only promoted phosphorylation of MAPK. Importantly, APO-modulated FGF-2 expression was independent of Akt/phosphoinositide 3-kinase signaling. These data suggest that APO can enhance biosynthesis and release of FGF-2 through activation of dopamine receptors in striatal astrocytes. Both cAMP/PKA and MEK/MAPK signaling cascades are major steps mediating this process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636101     DOI: 10.1096/fj.05-5510fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

1.  Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals.

Authors:  Jill R Bordelon-Glausier; Zafar U Khan; E Chris Muly
Journal:  J Comp Neurol       Date:  2008-06-20       Impact factor: 3.215

2.  TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson's Disease.

Authors:  Xiao Chen; Zhan Liu; Bei-Bei Cao; Yi-Hua Qiu; Yu-Ping Peng
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-20       Impact factor: 4.147

Review 3.  Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets.

Authors:  Kjell Fuxe; Luigi F Agnati; Manuela Marcoli; Dasiel O Borroto-Escuela
Journal:  Neurochem Res       Date:  2015-04-17       Impact factor: 3.996

4.  Acetylcholine α7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex.

Authors:  Aine M Duffy; Megan L Fitzgerald; June Chan; Danielle C Robinson; Teresa A Milner; Kenneth Mackie; Virginia M Pickel
Journal:  Synapse       Date:  2011-12       Impact factor: 2.562

5.  N-cadherin is a novel ERα anchor that protects against 6-OHDA damage to dopaminergic cells.

Authors:  Meng Wang; Feng Li; Zixiao Shi; Yaping Liu; Xiaozhou Wang; Li Li; Dianshuai Gao
Journal:  Cell Mol Neurobiol       Date:  2013-11-20       Impact factor: 5.046

Review 6.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

7.  Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin.

Authors:  Wei Shao; Shu-zhen Zhang; Mi Tang; Xin-hua Zhang; Zheng Zhou; Yan-qing Yin; Qin-bo Zhou; Yuan-yuan Huang; Ying-jun Liu; Eric Wawrousek; Teng Chen; Sheng-bin Li; Ming Xu; Jiang-ning Zhou; Gang Hu; Jia-wei Zhou
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962

8.  Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats.

Authors:  Richa B Tripathi; Dana M McTigue
Journal:  J Comp Neurol       Date:  2008-09-10       Impact factor: 3.215

9.  Ephrin-B2/EphA4 forward signaling is required for regulation of radial migration of cortical neurons in the mouse.

Authors:  Yan Hu; Sen Li; Hua Jiang; Ming-Tao Li; Jia-Wei Zhou
Journal:  Neurosci Bull       Date:  2014-01-29       Impact factor: 5.203

10.  Haloperidol changes mRNA expression of a QKI splice variant in human astrocytoma cells.

Authors:  Lin Jiang; Peter Saetre; Elena Jazin; Eva Lindholm Carlström
Journal:  BMC Pharmacol       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.